Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Concert Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Concert Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Concert Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Concert Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Concert Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Concert Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Concert Pharma Raises USD30 Million in Venture Debt Financing 10
Partnerships 11
Concert Pharma Enters Into Co-Development Agreement With Celgene 11
Concert Pharma Enters Into Co-Development Agreement With Fast Forward For C-21191 12
Licensing Agreements 13
Processa Pharma Enters into Licensing Agreement with Concert Pharma 13
Processa Pharma Enters into Option Licensing Agreement with Concert Pharma 14
Jazz Pharma Enters Into Licensing Agreement With Concert Pharma For C-10323 15
Concert Pharma Enters Into Licensing Agreement With AVANIR Pharma For Neurology And Psychiatry Drugs 17
Equity Offering 19
Concert Pharma Files Shelf Registration Statement with SEC to Raise USD250 Million 19
Concert Pharma Raises USD50 Million in Public Offering of Shares 20
Concert Pharma Completes Underwriters Exercise Of Over-Allotment Option Of IPO For US$93 Million 22
Asset Transactions 24
Vertex Pharma Acquires CTP-656 from Concert Pharma 24
Concert Pharmaceuticals Inc – Key Competitors 26
Concert Pharmaceuticals Inc – Key Employees 27
Concert Pharmaceuticals Inc – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Financial Announcements 29
Nov 01, 2018: Concert Pharmaceuticals reports third quarter 2018 financial results and provides company update 29
Aug 02, 2018: Concert Pharmaceuticals reports second quarter 2018 financial results and provides company update 30
May 03, 2018: Concert Pharmaceuticals Reports First Quarter 2018 Financial Results 31
Mar 01, 2018: Concert Pharmaceuticals Reports Year Ended 2017 Financial Results 33
Nov 09, 2017: Concert Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Company Update 34
Aug 08, 2017: Concert Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Company Update 35
May 02, 2017: Concert Pharmaceuticals Reports First Quarter 2017 Financial Results 37
Mar 06, 2017: Concert Pharmaceuticals Reports Year Ended 2016 Financial Results 38
Corporate Communications 40
Dec 18, 2017: Concert Pharmaceuticals Announces the Appointment of Marc Becker as Chief Financial Officer 40
Dec 13, 2017: Concert Pharmaceuticals to Be Added to NASDAQ Biotechnology Index 41
May 30, 2017: Concert Pharmaceuticals Announces Departure of Chief Financial Officer, Ryan Daws 42
Product News 43
02/28/2018: Concert Pharmaceuticals Announces Advancement of Novel Drug Candidate in Schizophrenia 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44
Concert Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Concert Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Concert Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Concert Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Concert Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Concert Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Concert Pharma Raises USD30 Million in Venture Debt Financing 10
Concert Pharma Enters Into Co-Development Agreement With Celgene 11
Concert Pharma Enters Into Co-Development Agreement With Fast Forward For C-21191 12
Processa Pharma Enters into Licensing Agreement with Concert Pharma 13
Processa Pharma Enters into Option Licensing Agreement with Concert Pharma 14
Jazz Pharma Enters Into Licensing Agreement With Concert Pharma For C-10323 15
Concert Pharma Enters Into Licensing Agreement With AVANIR Pharma For Neurology And Psychiatry Drugs 17
Concert Pharma Files Shelf Registration Statement with SEC to Raise USD250 Million 19
Concert Pharma Raises USD50 Million in Public Offering of Shares 20
Concert Pharma Completes Underwriters Exercise Of Over-Allotment Option Of IPO For US$93 Million 22
Vertex Pharma Acquires CTP-656 from Concert Pharma 24
Concert Pharmaceuticals Inc, Key Competitors 26
Concert Pharmaceuticals Inc, Key Employees 27
Concert Pharmaceuticals Inc, Subsidiaries 28
List of Figures
Concert Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Concert Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Concert Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Concert Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Concert Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Concert Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Concert Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Concert Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8